Centaurus Financial’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
– Sell
-10,000
Closed -$102K – 670
2020
Q2
$102K Buy
+10,000
New +$1.27M 0.02% 598

Other funds holding IBB

Centaurus Financial's IBB Position: Q3 2026 in Review

Centaurus Financial reduced its iShares Biotechnology ETF (IBB) stake by 1.8% in Q3 2026, selling an estimated $3.41K and leaving 927 shares worth $195K. The position accounts for 0.01% of the portfolio, ranked #885.

Centaurus Financial first reported a position in IBB in Q4 2017 and has held it in 30 quarters since. The position peaked at $509K in Q2 2021. 1,029 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • Centaurus Financial held 927 shares of iShares Biotechnology ETF worth $195K as of Q3 2026.
  • Centaurus Financial sold 17 iShares Biotechnology ETF shares in Q3 2026, an estimated $3.41K.
  • iShares Biotechnology ETF made up 0.01% of Centaurus Financial's portfolio in Q3 2026, its #885 holding.
  • Centaurus Financial first reported a position in iShares Biotechnology ETF in Q4 2017 and has held it in 30 quarters since.
  • Centaurus Financial's iShares Biotechnology ETF position peaked at $509K in Q2 2021.
  • 1,029 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Centaurus Financial's 13F filing for Q3 2026, filed 12 Nov 2026.